In 2023 the American Urological Association (AUA) requested an Update Literature Review (ULR) to incorporate new evidence generated since the 2019 publication of this Guideline. The resulting 2024 Guideline Amendment addresses updated recommendations to provide guidance for the care of patients with incontinence after prostate treatment (IPT).
In 2023, the IPT Guideline was updated through the AUA amendment process in which newly published literature is reviewed and integrated into previously published guidelines. There were 82 studies of interest initially identified in preliminary abstract review. Following full-text review, 17 studies met inclusion criteria and ultimately informed the statements of interest.
The Panel developed evidence- and consensus-based statements based on an updated review to provide guidance for the care of patients who experience IPT. These updates are detailed herein.
As prostate treatments are refined, a decreasing incidence of incontinence is anticipated. This Guideline will require further review as the diagnostic and treatment options for patients with IPT continue to evolve.
The Journal of urology. 2024 Jun 27 [Epub ahead of print]
Benjamin N Breyer, Sennett K Kim, Erin Kirkby, Alexis Marianes, Alex J Vanni, O Lenaine Westney
Department of Urology, University of California, San Francisco, San Francisco, California., American Urological Association, Linthicum, Maryland., Tucker, Georgia., Department of Urology, Lahey Hospital and Medical Center, Burlington, Massachusetts., Department of Urology, MD Anderson Cancer Center, Houston, Texas.